{"id":9049,"date":"2023-10-17T10:24:27","date_gmt":"2023-10-17T08:24:27","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=9049"},"modified":"2024-04-30T13:48:36","modified_gmt":"2024-04-30T11:48:36","slug":"innovative-complementary-and-alternative-therapy-in-inflammatory-bowel-diseases-a-broad-2020s-update","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/de\/professional\/scientific-corner\/innovative-complementary-and-alternative-therapy-in-inflammatory-bowel-diseases-a-broad-2020s-update\/","title":{"rendered":"Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Masi L, Ciuffini C, Petito V, Pisani LF, Lopetuso LR, Graziani C, Pugliese D, Laterza L, Puca P, Di Vincenzo F, Pizzoferrato M, Napolitano D, Turchini L, Amatucci V, Schiavoni E, Privitera G, Minordi LM, Mentella MC, Papa A, Armuzzi A, Gasbarrini A and Scaldaferri F\u00a0<em>Front. Gastroenterol.<\/em>\u00a01:1022530. doi: 10.3389\/fgstr.2022.1022530<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Inflammatory bowel diseases (IBD) are chronic disabling conditions with a complex and multifactorial etiology, which is still not completely understood. In the last 20 years, anti-TNF-\u03b1 antagonists have revolutionized the treatment of IBD, but many patients still do not respond or experience adverse events. Therefore, new biological therapies and small molecules, targeting several different pathways of gut inflammation, have been developed of which some have already been introduced in clinical practice while many others are currently investigated. Moreover, therapeutic procedures such as leukocytapheresis, fecal microbiota transplant and stem cell transplantation are currently being investigated for treating IBD. Lastly, complementary and alternative medicine has become a field of interest for gastroenterologist to reduce symptom burden in IBD patients. In this comprehensive and updated review, a novel classification of current and developing drugs is provided.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgstr.2022.1022530\/full\">Frontiers | Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update (frontiersin.org)<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Masi L, Ciuffini C, Petito V, Pisani LF, Lopetuso LR, Graziani C, Pugliese D, Laterza L, Puca P, Di Vincenzo F, Pizzoferrato M, Napolitano D, Turchini L, Amatucci V, Schiavoni E, Privitera G, Minordi LM, Mentella MC, Papa A, Armuzzi A, Gasbarrini A and Scaldaferri F\u00a0Front. Gastroenterol.\u00a01:1022530. doi: 10.3389\/fgstr.2022.1022530 Inflammatory bowel diseases (IBD) are chronic [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[760,92,134,759,424,426,478],"class_list":["post-9049","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-alternative","scientific_tags-anti-tnf","scientific_tags-biologics","scientific_tags-complementary","scientific_tags-gma","scientific_tags-ibd","scientific_tags-jak-inhibitors"],"acf":{"sc_authors":"<a href=\"https:\/\/www.frontiersin.org\/journals\/gastroenterology\/articles\/10.3389\/fgstr.2022.1022530\/full\">https:\/\/www.frontiersin.org\/journals\/gastroenterology\/articles\/10.3389\/fgstr.2022.1022530\/full<\/a>"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/innovative-complementary-and-alternative-therapy-in-inflammatory-bowel-diseases-a-broad-2020s-update\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Masi L, Ciuffini C, Petito V, Pisani LF, Lopetuso LR, Graziani C, Pugliese D, Laterza L, Puca P, Di Vincenzo F, Pizzoferrato M, Napolitano D, Turchini L, Amatucci V, Schiavoni E, Privitera G, Minordi LM, Mentella MC, Papa A, Armuzzi A, Gasbarrini A and Scaldaferri F\u00a0Front. Gastroenterol.\u00a01:1022530. doi: 10.3389\/fgstr.2022.1022530 Inflammatory bowel diseases (IBD) are chronic [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/innovative-complementary-and-alternative-therapy-in-inflammatory-bowel-diseases-a-broad-2020s-update\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-30T11:48:36+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/innovative-complementary-and-alternative-therapy-in-inflammatory-bowel-diseases-a-broad-2020s-update\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/innovative-complementary-and-alternative-therapy-in-inflammatory-bowel-diseases-a-broad-2020s-update\/\",\"name\":\"Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2023-10-17T08:24:27+00:00\",\"dateModified\":\"2024-04-30T11:48:36+00:00\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/innovative-complementary-and-alternative-therapy-in-inflammatory-bowel-diseases-a-broad-2020s-update\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/innovative-complementary-and-alternative-therapy-in-inflammatory-bowel-diseases-a-broad-2020s-update\/","og_locale":"de_DE","og_type":"article","og_title":"Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update - Adacyte","og_description":"Masi L, Ciuffini C, Petito V, Pisani LF, Lopetuso LR, Graziani C, Pugliese D, Laterza L, Puca P, Di Vincenzo F, Pizzoferrato M, Napolitano D, Turchini L, Amatucci V, Schiavoni E, Privitera G, Minordi LM, Mentella MC, Papa A, Armuzzi A, Gasbarrini A and Scaldaferri F\u00a0Front. Gastroenterol.\u00a01:1022530. doi: 10.3389\/fgstr.2022.1022530 Inflammatory bowel diseases (IBD) are chronic [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/innovative-complementary-and-alternative-therapy-in-inflammatory-bowel-diseases-a-broad-2020s-update\/","og_site_name":"Adacyte","article_modified_time":"2024-04-30T11:48:36+00:00","twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/innovative-complementary-and-alternative-therapy-in-inflammatory-bowel-diseases-a-broad-2020s-update\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/innovative-complementary-and-alternative-therapy-in-inflammatory-bowel-diseases-a-broad-2020s-update\/","name":"Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2023-10-17T08:24:27+00:00","dateModified":"2024-04-30T11:48:36+00:00","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/innovative-complementary-and-alternative-therapy-in-inflammatory-bowel-diseases-a-broad-2020s-update\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner\/9049","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/media?parent=9049"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific_tags?post=9049"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}